Table 1 Baseline characteristics of pediatric Cancer patients with SSTIs (n = 227)
Characteristic or Feature | Frequency (%) | Proportion (95% CI) |
|---|---|---|
Gender | Â | Â |
 Female | 96 (42.29) | 0.42 [0.36–0.49] |
 Male | 131 (57.71) | 0.58 [0.51–0.64] |
Age Group | Â | Â |
 <1 year | 5 (2.2) | 0.02 [0.01–0.05] |
 1–6 years | 90 (39.65) | 0.4 [0.33–0.46] |
 6–12 years | 73 (32.16) | 0.32 [0.26–0.38] |
 13–18 years | 58 (25.55) | 0.26 [0.2–0.32] |
 >18 years | 1 (0.44) | - |
Type of Malignancy | Â | Â |
 Solid Tumor | 88 (39.11) | 0.39 [0.33–0.46] |
 Hematologic | 129 (57.33) | 0.57 [0.51–0.63] |
 Non-malignant | 8 (3.56) | 0.04 [0.02–0.07] |
Malignancy Diagnosis | Â | Â |
 Leukemia | 91 (40.81) | 0.41 [0.35–0.47] |
 Lymphoma | 28 (12.56) | 0.13 [0.09–0.18] |
 Sarcoma | 43 (19.28) | 0.19 [0.15–0.25] |
 Nervous System Malignancies | 27 (12.11) | 0.12 [0.08–0.17] |
 Other Malignancies | 26 (11.66) | 0.12 [0.08–0.17] |
 Non-malignant Disorders | 8 (3.59) | 0.04 [0.02–0.07] |
Bloodstream Infection | Â | Â |
 Negative | 211 (92.95) | 0.93 [0.89–0.96] |
 Positive | 16 (7.05) | 0.07 [0.04–0.11] |
Febrile Neutropenia | Â | Â |
 Negative | 66 (30) | 0.3 [0.24–0.36] |
 Positive | 154 (70) | 0.7 [0.64–0.76] |
Infection Location | Â | Â |
 Limbs | 37 (71.15) | 0.71 [0.57–0.82] |
 Port | 13 (25) | 0.25 [0.15–0.39] |
 Bone and Bone Marrow | 1 (1.92) | 0.02 [0–0.13] |
 Other Sites | 1 (1.92) | 0.02 [0–0.13] |
White Blood Cell Count | Â | Â |
 <500 | 54 (24.55) | 0.25 [0.19–0.31] |
 500–999 | 25 (11.36) | 0.11 [0.08–0.16] |
 1000–1499 | 12 (5.45) | 0.05 [0.03–0.09] |
 1500–4999 | 62 (28.18) | 0.28 [0.23–0.35] |
 5000–15,000 | 44 (20) | 0.2 [0.15–0.26] |
 >15,000 | 23 (10.45) | 0.1 [0.07–0.15] |